Compare Stocks

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$9.65 -2.9%	$8.69	$7.11 ▼ $13.13	$45.74M	-0.46	3,252 shs	503 shs
NMRD Nemaura Medical	$0.05 -4.4%	$0.08	$0.05 ▼ $1.25	$2.19M	-0.06	80,895 shs	10,833 shs
PDEX Pro-Dex	$18.68 +1.2%	$17.66	$14.51 ▼ $22.99	$65.57M	0.6	7,894 shs	6,399 shs
TMDI Titan Medical	$0.14 -26.3%	$0.23	$0.13 ▼ $1.20	$15.67M	2.36	4.83 million shs	7.71 million shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	-2.92%	-0.92%	+11.56%	+12.21%	+964,999,900.00%
NMRD Nemaura Medical	-12.78%	-28.96%	-33.10%	-38.65%	-92.69%
PDEX Pro-Dex	-0.22%	-1.70%	+7.20%	-14.22%	+15.52%
TMDI Titan Medical	0.00%	0.00%	0.00%	0.00%	0.00%

Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NMRD Nemaura Medical	2.302 of 5 stars	3.5	0.0	0.0	4.5	0.0	1.7	0.0
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXR Daxor	N/A	N/A	N/A	N/A
NMRD Nemaura Medical	3.00	Buy	$2.50	4,512.55% Upside
PDEX Pro-Dex	N/A	N/A	N/A	N/A
TMDI Titan Medical	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A
NMRD Nemaura Medical	$80K	27.34	N/A	N/A	($0.41) per share	-0.13
PDEX Pro-Dex	$46.09M	1.42	$2.26 per share	8.26	$8.91 per share	2.10
TMDI Titan Medical	$20.09M	0.78	N/A	N/A	$0.32 per share	0.44

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXR Daxor	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NMRD Nemaura Medical	-$14.14M	-$0.39	N/A	∞	N/A	N/A	N/A	-142.69%	N/A
PDEX Pro-Dex	$7.07M	$0.75	24.91	∞	N/A	5.59%	8.97%	5.40%	5/2/2024 (Estimated)
TMDI Titan Medical	-$14.86M	-$0.19	N/A	∞	N/A	N/A	-167.03%	-112.15%	N/A

Latest PDEX, TMDI, DXR, and NMRD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/12/2024	Q3 2024	NMRD Nemaura Medical	N/A	-$0.12	-$0.12	-$0.17	N/A	N/A
2/8/2024	Q2 2024	PDEX Pro-Dex	N/A	$0.14	+$0.14	$0.14	N/A	$12.59 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXR Daxor	N/A	N/A	N/A	N/A	N/A
NMRD Nemaura Medical	N/A	N/A	N/A	N/A	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXR Daxor	N/A	N/A	N/A
NMRD Nemaura Medical	N/A	0.19	0.03
PDEX Pro-Dex	0.26	3.66	2.16
TMDI Titan Medical	N/A	1.41	1.41

Ownership

Institutional Ownership

Company	Institutional Ownership
DXR Daxor	1.34%
NMRD Nemaura Medical	4.41%
PDEX Pro-Dex	15.28%
TMDI Titan Medical	3.55%

Insider Ownership

Company	Insider Ownership
DXR Daxor	60.60%
NMRD Nemaura Medical	41.60%
PDEX Pro-Dex	42.60%
TMDI Titan Medical	0.02%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DXR Daxor	N/A	4.74 million	1.87 million	Not Optionable
NMRD Nemaura Medical	36	40.35 million	23.57 million	Optionable
PDEX Pro-Dex	145	3.51 million	2.02 million	Not Optionable
TMDI Titan Medical	49	111.95 million	111.93 million	Not Optionable

PDEX, TMDI, DXR, and NMRD Headlines

Source	Headline
	TMD:CA Titan Medical Inc. seekingalpha.com - April 21 at 9:46 AM
	Titan Medical Inc.: Titan Medical Reports Fiscal Year 2023 Results finanznachrichten.de - April 1 at 8:49 AM
	Titan Medical signs deal to merge with Conavi Medical msn.com - March 21 at 4:35 AM
	Titan Medical Inc TMDIF morningstar.com - February 27 at 7:19 PM
	Perifery appoints Titan Data Solutions as authorised distributor advanced-television.com - February 13 at 8:31 AM
	Titan Medical Inc (TMD) investing.com - February 13 at 1:56 AM
	Vantage Titan 3T MRI Scanner from Toshiba news-medical.net - January 11 at 8:10 AM
	Attack on Titan: Hajime Isayama Will Create New Titan Story in 2024 comicbook.com - October 3 at 1:41 AM
	Five dead on Titan sub were 'true explorers' - OceanGate bbc.com - September 28 at 10:21 PM
	TMDIF Titan Medical Inc. seekingalpha.com - August 1 at 7:27 PM
	False claim Titan passenger was the vice chairman of the World Economic Forum \| Fact check usatoday.com - July 25 at 1:09 PM
	New details emerge about discovery of Titan submersible debris en.as.com - July 19 at 9:22 AM
	Destiny 2 best Titan build for PvE and PvP videogamer.com - July 18 at 7:32 AM
	Presumed human remains found in Titan sub debris bbc.co.uk - July 14 at 5:59 PM
	The Titan submersible imploded, killing all 5 on board asahi.com - July 9 at 10:09 AM
	Debris and 'Presumed Human Remains' Recovered From Titan Submersible msn.com - June 30 at 7:39 PM
	US Coast Guard says 'presumed human remains' found in wreckage of Titan submersible wbaltv.com - June 30 at 1:27 PM
	Titan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic Ocean eonline.com - June 29 at 9:37 AM
	Possible human remains recovered from Titan wreckage, Coast Guard says msn.com - June 28 at 11:36 PM
	Titan submersible tragedy could lead to lawsuits and regulatory changes, experts say yahoo.com - June 24 at 12:27 PM
	What happens during a catastrophic implosion? Titan submersible occupants likely died instantly winknews.com - June 24 at 1:01 AM
	The science that put the Titan submersible at risk of implosion ktbs.com - June 24 at 1:01 AM
	The Titan submersible: What could have gone wrong? msn.com - June 21 at 2:23 PM
	Report: Banging sounds heard during Titan submersible search, according to internal memo wlox.com - June 21 at 12:43 AM

Media Sentiment Over Time

Company Descriptions

Daxor

NASDAQ:DXR

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Nemaura Medical

NASDAQ:NMRD

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Pro-Dex

NASDAQ:PDEX

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Titan Medical

NASDAQ:TMDI

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial